Mio Matsubara
Yamanashi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Comparison of surgical outcomes between iStent and iStent inject W with ≥2 years of follow-up: a propensity score matching analysis.
Journal: Japanese journal of ophthalmology
Published: September 30, 2025
Clinical and genetic characteristics of simple central serous chorioretinopathy according to age.
Journal: Ophthalmic genetics
Published: November 11, 2024
Association of Polyp Regression after Loading Phase with 12-Month Outcomes of Eyes with Polypoidal Choroidal Vasculopathy.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 03, 2024
INCIDENCE AND CHARACTERISTICS OF NEOVASCULAR AGE-RELATED MACULAR WITH OVER A 12-MONTH REMISSION AFTER THREE MONTHLY AFLIBERCEPT ADMINISTRATION: 60 Months Results of a Pro Re Nata Regimen.
Journal: Retina (Philadelphia, Pa.)
Published: February 20, 2024
A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 25, 2023
Repeated Measurements Are Necessary for Evaluating Accurate Diurnal Rhythm Using a Self-Intraocular Pressure Measurement Device.
Journal: Journal of clinical medicine
Published: February 06, 2023
DISTINCT CHARACTERISTICS OF SIMPLE VERSUS COMPLEX CENTRAL SEROUS CHORIORETINOPATHY.
Journal: Retina (Philadelphia, Pa.)
Published: February 02, 2023
Comparison of one-year outcomes between as-needed brolucizumab and aflibercept for polypoidal choroidal vasculopathy.
Journal: Japanese journal of ophthalmology
Published: January 18, 2023
Mid-Term Results of Ab Interno Trabeculectomy among Japanese Glaucoma Patients.
Journal: Journal of clinical medicine
Published: December 07, 2022
Characteristics of intermediate age-related macular degeneration with hyperreflective foci.
Journal: Scientific reports
Published: October 09, 2022
Distinct characteristics of central serous chorioretinopathy according to gender.
Journal: Scientific reports
Published: February 17, 2022
The combination therapy of subtenon triamcinolone acetonide injection and intravitreal brolucizumab for brolucizumab-related intraocular inflammation.
Journal: Medicine
Published: August 13, 2021
Last Updated: 09/26/2026